Objective To evaluate the agreement of chemotherapy effect between RECIST and WHO criteria.
目的评价RECIST和WHO标准在肺癌化疗疗效评价中的一致性。
RECIST(Response Evaluation Criteria In Solid Tumors) was adopted as the new criteria recently.
RECIST已成为目前国际肿瘤界采用的新标准。
The primary end point was overall response rate (ORR) per investigator assessment (RECIST 1.1).
主要研究终点为总缓解率(ORR)，采用评价标准为RECIST 1.1。
The primary end point was overall response rate (ORR) per investigator assessment (RECIST 1.1).
主要研究终点为总缓解率(ORR)，采用评价标准为RECIST 1.1。
应用推荐